# Aytul Ercil

> Aytul Ercil is a seed investor at Vispera (Istanbul) backing Biotechnology and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Vispera](https://shizune.co/investors/profile/vispera)
- Location: Istanbul, Turkey
- Total investments: 3
- Last investment: Mar 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://tr.linkedin.com/in/aytul-ercil-b833b43

Aytul Ercil is a seed investor at Vispera in Istanbul focused on Biotechnology and Biopharma. Aytul Ercil - Founding Partner & Co-CEO @ Vispera

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Biopharma | 1 | 33% |
| Life Science | 1 | 33% |
| Manufacturing | 1 | 33% |
| Plastics and Rubber Manufacturing | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Funding Round | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PhiTech Bioinformatics | PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K |  | Mar 22, 2023 |  |
| PhiTech Bioinformatics | PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. | $280K | Seed | Mar 22, 2023 |  |
| Biolive | BIOLIVE was founded as a start-up company in Incubation Centre at Istanbul Technical University in 2016. The company transitioned to becoming a corporation with an investment from Vestel Ventures, a subsidiary of Zorlu Holding in 2017. Currently, the company produces bioplastic raw materials such as Bio-PE, Bio-PP, and Bio-ABS in scale-up andnext-gen materials such as plant-based leather and also offers sustainable solutions. |  | Series A | Mar 02, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [Istcapital](https://shizune.co/investors/profile/istcapital) — VC Fund, 2 deals together
- [Omurga Capital](https://shizune.co/investors/profile/omurga-gayrimenkul-portf%C3%B6y) — VC Fund, 2 deals together
- [212](https://shizune.co/investors/profile/212-capital-partners) — VC Fund, 1 deal together
- [CHS Industrial Products](https://shizune.co/investors/profile/chs-industrial-products) — VC Fund, 1 deal together
- [Keiretsu Forum](https://shizune.co/investors/profile/keiretsu-forum) — VC Fund, 1 deal together
- [Keiretsu Forum Turkey](https://shizune.co/investors/profile/keiretsu-forum-turkey) — VC Fund, 1 deal together

## About Vispera

VC Fund · Istanbul, Turkey

Vispera is an image recognition and analytics company that runs its proprietary technology. With that, we provide retailers and suppliers with the missing insights they need for better performance at all points of sale. The image recognition based automation we provide helps our clients monitor the performance of their in-store execution and takecorrective actions.Our business technology solutions have been shaped into products that help boost productivity for field operations and improve in-store performance of display units. We provide real-time data and guidance on the field team performance, as well as key retail execution metrics such as on-shelf availability, planogram compliance, shelf share, price tag readings, branding material visibility, etc. Among these metrics, problems with on-shelf-availability alone cost the retail sector 1.75 Trillion USD each year. Delivering and commoditizing IR services require expert knowledge which we have. Due to our high performance in accuracy, reporting dashboard flexibility and customer satisfaction we are recently seeing competitors’ clients convert to Vispera services. We maintain our technological edge as well as a robust but flexible product strategy.We want to make image recognition a commodity service for the global retail sector and enable perfect store execution and experience for retailers, suppliers and consumers alike. As such, we progressively move from an IR vendor into retail data analytics provider supported by IR-based evidential reality.

4 contacts available at Vispera.

| Name | Title | Profile |
| --- | --- | --- |
| Aytul Ercil | Founding Partner & Co-CEO | https://shizune.co/investors/profile/aytul-ercil |
| Beni Melamet | Partnering and Alliances Director | https://shizune.co/investors/profile/beni-melamet |
| Ceyhun Burak Akgül | Founding Partner, Co-CEO | https://shizune.co/investors/profile/ceyhun-burak-akgul |
| Erdem Yoruk | CTO | https://shizune.co/investors/profile/erdem-yoruk |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors in Middle East](https://shizune.co/investors/biotech-angel-investors-middle-east)
- [Biotechnology Angel Investors in Turkey](https://shizune.co/investors/biotechnology-angel-investors-turkey)
- [Biotech Angel Investors in Turkey](https://shizune.co/investors/biotech-angel-investors-turkey)
- [Biotechnology Investors in Middle East](https://shizune.co/investors/biotechnology-investors-middle-east)
- [Biotech Investors in Middle East](https://shizune.co/investors/biotech-investors-middle-east)
- [Health Care Angel Investors in Turkey](https://shizune.co/investors/health-care-angel-investors-turkey)

## FAQ

### What does Aytul Ercil invest in?

Aytul Ercil invests primarily in Biotechnology, Biopharma and Life Science startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Aytul Ercil last invest?

The most recent investment recorded for Aytul Ercil closed in Mar 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co